These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23269224)

  • 1. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
    Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Marín-Jiménez I; Nos P; Domènech E; Riestra S; Gisbert JP; Calvet X; Cortés X; Iglesias E; Huguet JM; Taxonera C; Fernández R; Carpio D; Gutiérrez A; Guardiola J; Laria LC; Sicilia B; Bujanda L; Cea-Calvo L; Romero C; Rincón Ó; Juliá B; Panés J
    Am J Gastroenterol; 2016 Feb; 111(2):261-8. PubMed ID: 26753886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity.
    Bennebroek Evertsz' F; Hoeks CC; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Clin Gastroenterol; 2013; 47(10):850-6. PubMed ID: 23632348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the physician-completed and the patient-completed simple clinical colitis activity index (SCCAI).
    Walmsley RS; Casey P
    J Crohns Colitis; 2013 Dec; 7(11):930-1. PubMed ID: 23849400
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.
    Bewtra M; Brensinger CM; Tomov VT; Hoang TB; Sokach CE; Siegel CA; Lewis JD
    Inflamm Bowel Dis; 2014 Jun; 20(6):1070-8. PubMed ID: 24810138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
    Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
    Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform.
    Mangia M; Giuffrida E; Figini V; Colombo A; Carli E; Lavagna A; Mendolaro M; Morello E; Cosimato M; Rocca R; Pagana G; Daperno M
    Scand J Gastroenterol; 2023 Mar; 58(3):240-247. PubMed ID: 36148538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining relapse of ulcerative colitis using a symptom-based activity index.
    Jowett SL; Seal CJ; Phillips E; Gregory W; Barton JR; Welfare MR
    Scand J Gastroenterol; 2003 Feb; 38(2):164-71. PubMed ID: 12678333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.
    Spiegel BM; Ho W; Esrailian E; Targan S; Higgins PD; Siegel CA; Dubinsky M; Melmed GY
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):168-74, 174.e1. PubMed ID: 18952199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores.
    Lee JJ; Colman RJ; Mitchell PD; Atmadja ML; Bousvaros A; Lightdale JR
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):708-13. PubMed ID: 21593644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
    Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
    J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma viscosity: a potential predictor of both medical treatment response and clinical stage of ulcerative colitis.
    Yakar T; Cosar AM; Gokturk HS; Kanat UG; Parlakgumus A; Kozanoglu I; Serin E
    Ann Ital Chir; 2016; 87():531-543. PubMed ID: 28070034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing disease activity indices in ulcerative colitis.
    Walsh AJ; Ghosh A; Brain AO; Buchel O; Burger D; Thomas S; White L; Collins GS; Keshav S; Travis SP
    J Crohns Colitis; 2014 Apr; 8(4):318-25. PubMed ID: 24120021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial.
    Krag A; Munkholm P; Israelsen H; von Ryberg B; Andersen KK; Bendtsen F
    Inflamm Bowel Dis; 2013 Nov; 19(12):2584-92. PubMed ID: 24108114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool.
    Ghosh S; Sensky T; Casellas F; Rioux LC; Ahmad T; Márquez JR; Vanasek T; Gubonina I; Sezgin O; Ardizzone S; Kligys K; Petersson J; Suzuki Y; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Jul; 15(2):228-37. PubMed ID: 32722760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Castaneda G; Liu B; Torres S; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Oct; 62(10):2876-2881. PubMed ID: 28856475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the Montreal classification for inflammatory bowel diseases.
    Spekhorst LM; Visschedijk MC; Alberts R; Festen EA; van der Wouden EJ; Dijkstra G; Weersma RK;
    World J Gastroenterol; 2014 Nov; 20(41):15374-81. PubMed ID: 25386087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
    Tinsley A; Macklin EA; Korzenik JR; Sands BE
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1328-36. PubMed ID: 21999576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.